Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2026-02-17

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.8bn reported value +36.6% vs Q3 2025
103positions
47.4%in top 10
35 new 37 added 29 reduced 15 sold out vs Q3 2025

Options: 0 call positions (— notional), 4 put positions ($201.0m notional) – listed below, not included above.

Holdings, Q4 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VERA THERAPEUTICS INC CL A VERA VERA 3,072,304 $155.6m8.72% 8.72% AddedShares held: Q1 2025 1.9m, Q2 2025 2.4m, Q3 2025 2.8m, Q4 2025 3.1m +264.5k +264,468 9.4%
2 GSK PLC SPONSORED ADR GSK GSK 2,679,721 $131.4m7.37% 7.37% AddedShares held: Q1 2025 2.6m, Q2 2025 2.2m, Q3 2025 2.1m, Q4 2025 2.7m +559.3k +559,275 26.4%
3 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 252,592 $123.1m6.90% 6.90% ReducedShares held: Q1 2025 57.5k, Q2 2025 59.4k, Q3 2025 253.2k, Q4 2025 252.6k -628 -628 -0.2%
4 ABIVAX SA SPONSORED ADS ABVX ABVX 657,834 $88.7m4.97% 4.97% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 426.5k, Q4 2025 657.8k +231.3k +231,335 54.2%
5 NATERA INC COM NTRA NTRA 334,493 $76.6m4.30% 4.30% ReducedShares held: Q1 2025 893.7k, Q2 2025 796.4k, Q3 2025 519.6k, Q4 2025 334.5k -185.2k -185,151 -35.6%
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,314,408 $69.6m3.90% 3.90% ReducedShares held: Q1 2025 4.2m, Q2 2025 4.1m, Q3 2025 3.5m, Q4 2025 3.3m -152.9k -152,906 -4.4%
7 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,782,235 $55.5m3.11% 3.11% ReducedShares held: Q1 2025 1.4m, Q2 2025 1.9m, Q3 2025 1.9m, Q4 2025 1.8m -142.1k -142,071 -7.4%
8 VAXCYTE INC COM PCVX PCVX 1,197,722 $55.3m3.10% 3.10% ReducedShares held: Q1 2025 557.1k, Q2 2025 1.3m, Q3 2025 1.4m, Q4 2025 1.2m -224.3k -224,261 -15.8%
9 TRAVERE THERAPEUTICS INC COM TVTX TVTX 1,174,968 $44.9m2.52% 2.52% ReducedShares held: Q1 2025 816.3k, Q2 2025 1.3m, Q3 2025 1.4m, Q4 2025 1.2m -242.2k -242,236 -17.1%
10 HCA HEALTHCARE INC COM HCA HCA 95,874 $44.8m2.51% 2.51% ReducedShares held: Q1 2025 152.5k, Q2 2025 100.0k, Q3 2025 111.7k, Q4 2025 95.9k -15.8k -15,826 -14.2%
11 DANAHER CORPORATION COM DHR DHR 186,262 $42.6m2.39% 2.39% AddedShares held: Q1 2025 0, Q2 2025 23.4k, Q3 2025 99.3k, Q4 2025 186.3k +87.0k +86,989 87.6%
12 IONIS PHARMACEUTICALS INC COM IONS IONS 538,218 $42.6m2.39% 2.39% ReducedShares held: Q1 2025 517.0k, Q2 2025 588.9k, Q3 2025 538.7k, Q4 2025 538.2k -443 -443 -0.1%
13 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 1,434,725 $39.0m2.18% 2.18% AddedShares held: Q1 2025 696.5k, Q2 2025 838.7k, Q3 2025 1.2m, Q4 2025 1.4m +280.8k +280,805 24.3%
14 BRUKER CORP COM BRKR BRKR 783,789 $36.9m2.07% 2.07% AddedShares held: Q1 2025 499.2k, Q2 2025 839.3k, Q3 2025 687.1k, Q4 2025 783.8k +96.7k +96,660 14.1%
15 AVANTOR INC COM AVTR AVTR 3,176,644 $36.4m2.04% 2.04% AddedShares held: Q1 2025 122.8k, Q2 2025 1.5m, Q3 2025 924.4k, Q4 2025 3.2m +2.3m +2,252,202 243.6%
16 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 7,943,802 $24.8m1.39% 1.39% AddedShares held: Q1 2025 8.5m, Q2 2025 6.1m, Q3 2025 7.0m, Q4 2025 7.9m +993.8k +993,751 14.3%
17 EXACT SCIENCES CORP COM EXAS EXAS 241,678 $24.5m1.38% 1.38% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 241.7k
18 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 2,992,895 $23.3m1.31% 1.31% AddedShares held: Q1 2025 2.2m, Q2 2025 1.2m, Q3 2025 1.4m, Q4 2025 3.0m +1.6m +1,619,270 117.9%
19 GERON CORP COM GERN GERN 17,659,983 $23.3m1.31% 1.31% AddedShares held: Q1 2025 0, Q2 2025 7.3m, Q3 2025 12.6m, Q4 2025 17.7m +5.1m +5,060,981 40.2%
20 BIO-TECHNE CORP COM TECH TECH 377,405 $22.2m1.24% 1.24% ReducedShares held: Q1 2025 280.1k, Q2 2025 394.1k, Q3 2025 591.5k, Q4 2025 377.4k -214.1k -214,135 -36.2%
21 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 98,721 $21.8m1.22% 1.22% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 98.7k
22 INSULET CORP COM PODD PODD 74,708 $21.2m1.19% 1.19% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 45.6k, Q4 2025 74.7k +29.1k +29,104 63.8%
23 BETA BIONICS INC COM BBNX BBNX 678,262 $20.7m1.16% 1.16% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 678.3k
24 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 660,177 $20.6m1.16% 1.16% ReducedShares held: Q1 2025 1.4m, Q2 2025 1.1m, Q3 2025 1.4m, Q4 2025 660.2k -703.5k -703,476 -51.6%
25 UNITEDHEALTH GROUP INC COM UNH UNH 60,862 $20.1m1.13% 1.13% ReducedShares held: Q1 2025 0, Q2 2025 60.7k, Q3 2025 62.8k, Q4 2025 60.9k -2.0k -1,958 -3.1%
26 LIQUIDIA CORPORATION COM NEW LQDA LQDA 509,443 $17.6m0.99% 0.99% AddedShares held: Q1 2025 150.5k, Q2 2025 358.8k, Q3 2025 486.0k, Q4 2025 509.4k +23.4k +23,422 4.8%
27 ICON PLC SHS ICLR ICLR 95,832 $17.5m0.98% 0.98% AddedShares held: Q1 2025 10.8k, Q2 2025 64.6k, Q3 2025 55.0k, Q4 2025 95.8k +40.8k +40,807 74.2%
28 HEALTHEQUITY INC COM HQY HQY 185,739 $17.0m0.95% 0.95% AddedShares held: Q1 2025 352.0k, Q2 2025 155.9k, Q3 2025 52.4k, Q4 2025 185.7k +133.4k +133,351 254.5%
29 GLAUKOS CORP COM GKOS GKOS 147,471 $16.7m0.93% 0.93% NewShares held: Q1 2025 159.0k, Q2 2025 31.5k, Q3 2025 0, Q4 2025 147.5k
30 PERKINELMER INC COM RVTY RVTY 162,777 $15.7m0.88% 0.88% ReducedShares held: Q1 2025 299.1k, Q2 2025 510.3k, Q3 2025 394.3k, Q4 2025 162.8k -231.5k -231,534 -58.7%
31 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 420,827 $14.8m0.83% 0.83% ReducedShares held: Q1 2025 281.0k, Q2 2025 414.4k, Q3 2025 488.6k, Q4 2025 420.8k -67.8k -67,765 -13.9%
32 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 3,851,133 $14.2m0.80% 0.80% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 3.9m
33 BIOGEN INC COM BIIB BIIB 77,944 $13.7m0.77% 0.77% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 51.8k, Q4 2025 77.9k +26.2k +26,179 50.6%
34 SELECT MED HLDGS CORP COM SEM SEM 906,100 $13.5m0.75% 0.75% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 906.1k
35 CENTENE CORP DEL COM CNC CNC 324,092 $13.3m0.75% 0.75% AddedShares held: Q1 2025 340.3k, Q2 2025 398.7k, Q3 2025 224.6k, Q4 2025 324.1k +99.5k +99,542 44.3%
36 CG ONCOLOGY INC COM CGON CGON 308,466 $12.8m0.72% 0.72% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 308.5k
37 BRISTOL-MYERS SQUIBB CO COM BMY BMY 235,293 $12.7m0.71% 0.71% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 235.3k
38 PALISADE BIO INC COM PALI PALI 5,391,548 $12.7m0.71% 0.71% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 5.4m
39 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 434,634 $12.6m0.71% 0.71% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 111.5k, Q4 2025 434.6k +323.2k +323,168 289.9%
40 PHARVARIS N V COM PHVS PHVS 439,177 $12.2m0.68% 0.68% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 439.2k
41 ELI LILLY & CO COM LLY LLY 10,623 $11.4m0.64% 0.64% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 10.6k
42 ENCOMPASS HEALTH CORP COM EHC EHC 106,926 $11.3m0.64% 0.64% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 106.9k
43 CYTOMX THERAPEUTICS INC COM CTMX CTMX 2,507,090 $10.7m0.60% 0.60% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 2.5m
44 ELEVANCE HEALTH INC COM ELV ELV 30,195 $10.6m0.59% 0.59% ReducedShares held: Q1 2025 15.7k, Q2 2025 19.0k, Q3 2025 45.0k, Q4 2025 30.2k -14.8k -14,785 -32.9%
45 MANNKIND CORP COM NEW MNKD MNKD 1,852,563 $10.5m0.59% 0.59% ReducedShares held: Q1 2025 697.7k, Q2 2025 697.7k, Q3 2025 2.0m, Q4 2025 1.9m -190.2k -190,164 -9.3%
46 XENON PHARMACEUTICALS INC COM XENE XENE 231,380 $10.4m0.58% 0.58% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 231.4k
47 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 48,241 $10.3m0.58% 0.58% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 48.2k
48 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 18,062 $10.2m0.57% 0.57% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 14.4k, Q4 2025 18.1k +3.6k +3,636 25.2%
49 ILLUMINA INC COM ILMN ILMN 76,721 $10.1m0.56% 0.56% ReducedShares held: Q1 2025 0, Q2 2025 198.6k, Q3 2025 123.7k, Q4 2025 76.7k -47.0k -46,953 -38.0%
50 ARDELYX INC COM ARDX ARDX 1,715,129 $10.0m0.56% 0.56% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 1.4m, Q4 2025 1.7m +285.8k +285,752 20.0%
51 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 605,976 $9.3m0.52% 0.52% ReducedShares held: Q1 2025 0, Q2 2025 1.2m, Q3 2025 693.5k, Q4 2025 606.0k -87.6k -87,551 -12.6%
52 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 127,561 $8.9m0.50% 0.50% ReducedShares held: Q1 2025 0, Q2 2025 99.3k, Q3 2025 166.4k, Q4 2025 127.6k -38.8k -38,830 -23.3%
53 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 337,340 $8.4m0.47% 0.47% ReducedShares held: Q1 2025 0, Q2 2025 392.7k, Q3 2025 502.2k, Q4 2025 337.3k -164.9k -164,894 -32.8%
54 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 358,168 $8.4m0.47% 0.47% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 350.8k, Q4 2025 358.2k +7.4k +7,356 2.1%
55 HUMANA INC COM HUM HUM 32,462 $8.3m0.47% 0.47% AddedShares held: Q1 2025 28.0k, Q2 2025 43.6k, Q3 2025 16.7k, Q4 2025 32.5k +15.8k +15,810 94.9%
56 PENNANT GROUP INC COM PNTG PNTG 293,960 $8.3m0.46% 0.46% AddedShares held: Q1 2025 0, Q2 2025 38.0k, Q3 2025 38.0k, Q4 2025 294.0k +256.0k +255,980 674.0%
57 MODERNA INC COM MRNA MRNA 267,823 $7.9m0.44% 0.44% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 267.8k
58 MOLINA HEALTHCARE INC COM MOH MOH 45,470 $7.9m0.44% 0.44% AddedShares held: Q1 2025 23.7k, Q2 2025 20.6k, Q3 2025 9.5k, Q4 2025 45.5k +36.0k +36,000 380.1%
59 REGENERON PHARMACEUTICALS COM REGN REGN 10,097 $7.8m0.44% 0.44% ReducedShares held: Q1 2025 0, Q2 2025 13.3k, Q3 2025 16.7k, Q4 2025 10.1k -6.6k -6,623 -39.6%
60 TYRA BIOSCIENCES INC COM TYRA TYRA 278,564 $7.3m0.41% 0.41% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 272.7k, Q4 2025 278.6k +5.9k +5,858 2.1%
61 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 317,182 $7.3m0.41% 0.41% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 317.2k
62 ANAPTYSBIO INC COM ANAB ANAB 120,927 $5.9m0.33% 0.33% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 120.9k
63 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 93,748 $5.6m0.31% 0.31% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 146.6k, Q4 2025 93.7k -52.9k -52,894 -36.1%
64 ASSEMBLY BIOSCIENCES INC COM NEW ASMB ASMB 159,676 $5.4m0.30% 0.30% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 159.7k
65 INVIVYD INC COM IVVD IVVD 2,140,130 $5.3m0.30% 0.30% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 2.0m, Q4 2025 2.1m +92.9k +92,865 4.5%
66 CVS HEALTH CORP COM CVS CVS 63,696 $5.1m0.28% 0.28% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 63.7k
67 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 176,594 $4.7m0.26% 0.26% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 164.2k, Q4 2025 176.6k +12.4k +12,357 7.5%
68 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 52,961 $4.6m0.26% 0.26% NewShares held: Q1 2025 547.1k, Q2 2025 277.3k, Q3 2025 0, Q4 2025 53.0k
69 ZENAS BIOPHARMA INC COM ZBIO ZBIO 121,016 $4.4m0.25% 0.25% ReducedShares held: Q1 2025 445.6k, Q2 2025 325.5k, Q3 2025 158.7k, Q4 2025 121.0k -37.7k -37,726 -23.8%
70 RELAY THERAPEUTICS INC COM RLAY RLAY 489,137 $4.1m0.23% 0.23% AddedShares held: Q1 2025 0, Q2 2025 533.4k, Q3 2025 479.1k, Q4 2025 489.1k +10.1k +10,081 2.1%
71 ENGENE HOLDINGS INC COM COM 455,835 $4.1m0.23% 0.23% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 455.8k
72 BROOKDALE SR LIVING INC COM BKD BKD 374,929 $4.0m0.23% 0.23% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 374.9k
73 NATIONAL HEALTHCARE CORP COM NHC NHC 28,577 $3.9m0.22% 0.22% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 28.6k
74 FORTREA HLDGS INC COMMON STOCK FTRE FTRE 224,139 $3.9m0.22% 0.22% AddedShares held: Q1 2025 293.3k, Q2 2025 219.4k, Q3 2025 219.4k, Q4 2025 224.1k +4.8k +4,755 2.2%
75 BIOVENTUS INC COM CL A BVS BVS 471,257 $3.5m0.20% 0.20% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 433.9k, Q4 2025 471.3k +37.3k +37,324 8.6%
76 ARS PHARMACEUTICALS INC COM SPRY SPRY 251,593 $2.9m0.16% 0.16% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 976.5k, Q4 2025 251.6k -724.9k -724,918 -74.2%
77 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 500,000 $2.5m0.14% 0.14% UnchangedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 500.0k, Q4 2025 500.0k
78 AMARIN CORP PLC SPONSORED ADR AMRN AMRN 172,188 $2.4m0.13% 0.13% AddedShares held: Q1 2025 0, Q2 2025 167.3k, Q3 2025 167.3k, Q4 2025 172.2k +4.9k +4,912 2.9%
79 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 718,582 $2.3m0.13% 0.13% AddedShares held: Q1 2025 942.5k, Q2 2025 640.7k, Q3 2025 290.7k, Q4 2025 718.6k +427.9k +427,909 147.2%
80 EVOLUS INC COM EOLS EOLS 344,104 $2.3m0.13% 0.13% ReducedShares held: Q1 2025 0, Q2 2025 1.2m, Q3 2025 1.5m, Q4 2025 344.1k -1.1m -1,131,005 -76.7%
81 SUTRO BIOPHARMA INC COM SHS STRO STRO 193,571 $2.2m0.13% 0.13% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 193.6k
82 SURROZEN INC COM NEW SRZN SRZN 95,286 $2.2m0.12% 0.12% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 77.0k, Q4 2025 95.3k +18.3k +18,289 23.8%
83 ENHABIT INC COM EHAB EHAB 218,510 $2.0m0.11% 0.11% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 218.5k
84 RAPPORT THERAPEUTICS INC COM RAPP RAPP 59,233 $1.8m0.10% 0.10% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 143.6k, Q4 2025 59.2k -84.3k -84,332 -58.7%
85 INFLARX NV COM IFRX IFRX 1,757,312 $1.8m0.10% 0.10% AddedShares held: Q1 2025 1.7m, Q2 2025 1.6m, Q3 2025 1.7m, Q4 2025 1.8m +26.7k +26,677 1.5%
86 BIOHAVEN LTD COM BHVN BHVN 145,431 $1.6m0.09% 0.09% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 145.4k
87 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 137,493 $1.6m0.09% 0.09% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 134.6k, Q4 2025 137.5k +2.9k +2,874 2.1%
88 ALECTOR INC COM ALEC ALEC 1,006,163 $1.6m0.09% 0.09% ReducedShares held: Q1 2025 617.4k, Q2 2025 2.0m, Q3 2025 1.5m, Q4 2025 1.0m -482.6k -482,562 -32.4%
89 NOVOCURE LTD ORD SHS NVCR NVCR 120,978 $1.6m0.09% 0.09% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 121.0k
90 UNIQURE NV SHS QURE QURE 62,820 $1.5m0.08% 0.08% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 877.4k, Q4 2025 62.8k -814.6k -814,553 -92.8%
91 PASSAGE BIO INC COM NEW PASG PASG 126,230 $1.5m0.08% 0.08% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 126.2k
92 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 178,915 $1.3m0.07% 0.07% ReducedShares held: Q1 2025 0, Q2 2025 211.5k, Q3 2025 194.4k, Q4 2025 178.9k -15.5k -15,525 -8.0%
93 NOVAVAX INC COM NEW NVAX NVAX 181,220 $1.2m0.07% 0.07% ReducedShares held: Q1 2025 365.5k, Q2 2025 0, Q3 2025 243.2k, Q4 2025 181.2k -62.0k -61,964 -25.5%
94 PLIANT THERAPEUTICS INC COM PLRX PLRX 842,023 $1.0m0.06% 0.06% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 824.6k, Q4 2025 842.0k +17.4k +17,429 2.1%
95 SAVARA INC COM SVRA SVRA 170,195 $1.0m0.06% 0.06% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 170.2k
96 EHEALTH INC COM EHTH EHTH 222,570 $1.0m0.06% 0.06% AddedShares held: Q1 2025 89.2k, Q2 2025 128.3k, Q3 2025 128.3k, Q4 2025 222.6k +94.2k +94,248 73.5%
97 INMODE LTD SHS INMD INMD 61,938 $909.9k0.05% 0.05% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 61.9k
98 AADI BIOSCIENCE INC COM WHWK WHWK 260,259 $629.8k0.04% 0.04% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 260.3k
99 EDITAS MEDICINE INC COM EDIT EDIT 290,919 $596.4k0.03% 0.03% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 290.9k
100 SELECTQUOTE INC COM SLQT SLQT 357,661 $504.3k0.03% 0.03% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 357.7k

Sold out since Q3 2025

SecurityTickerShares held beforeValue then
ZIMVIE INC ZIMV ZIMV 2,079,380 $39.4m2.1m shares
REPLIGEN CORP RGEN RGEN 105,087 $14.0m105.1k shares
AVIDITY BIOSCIENCES INC RNA RNA 302,911 $13.2m302.9k shares
NOVO-NORDISK A S NVO NVO 217,708 $12.1m217.7k shares
89BIO INC ETNB ETNB 392,441 $5.8m392.4k shares
MERUS N V MRUS MRUS 48,054 $4.5m48.1k shares
MIRUM PHARMACEUTICALS INC MIRM MIRM 49,314 $3.6m49.3k shares
NEKTAR THERAPEUTICS NKTR NKTR 49,890 $2.8m49.9k shares
GOSSAMER BIO INC GOSS GOSS 925,233 $2.4m925.2k shares
KURA ONCOLOGY INC KURA KURA 263,628 $2.3m263.6k shares
SUTRO BIOPHARMA INC 229,131 $2.0m229.1k shares
KORRO BIO INC KRRO KRRO 20,856 $998.8k20.9k shares
PALVELLA THERAPEUTICS INC NE PVLA PVLA 11,343 $711.1k11.3k shares
REPLIMUNE GROUP INC REPL REPL 59,992 $251.4k60.0k shares
DYNE THERAPEUTICS INC DYN DYN 10,000 $126.5k10.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 225,000 $138.2m225.0k shares Reduced
SPDR S&P 500 ETF TR SPY · Put SPYPut 44,900 $30.6m44.9k shares New
ISHARES TR TLT · Put TLTPut 230,000 $20.0m230.0k shares New
SPDR SER TR XBI · Put XBIPut 99,400 $12.1m99.4k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17